Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults (over 18 years old) who have a type of slow-growing blood cancer called follicular non-Hodgkin's lymphoma, and who have already tried at least two different treatments for it
- People who are receiving a drug called mosunetuzumab through a special compassionate use program (a program that allows access to medicines not yet widely approved)
- People who have given their written agreement to take part in the treatment
Who may not be able to join:
- People under 18 years of age
- People whose cancer is a different type of lymphoma or a different cancer altogether
- People who do not meet the requirements for the mosunetuzumab compassionate use program (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0226439396
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the response to Mosu (Lugano criteria); Disease-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.